Inquiry Basket
Loading ......
Filter By Product Search for
LCMV
LCMV Full Name
Lymphocytic choriomeningitis virus
LCMV Introduction
Researchers and clinicians studying viral meningitis or unexplained neurological infections often face a major challenge: identifying underrecognized pathogens that may evade routine diagnostic panels. Lymphocytic choriomeningitis virus (LCMV) is one such pathogen. LCMV is an enveloped, single-stranded RNA virus belonging to the Arenaviridae family and is primarily maintained in rodent reservoirs, particularly the common house mouse (Mus musculus). Humans typically become infected through inhalation of aerosolized particles from rodent urine, feces, or saliva, or through direct contact with infected animals such as pet hamsters. Despite being one of the earliest discovered human arenaviruses, LCMV remains widely underdiagnosed due to limited awareness and restricted availability of serological and molecular testing. Recent reviews have highlighted that the global disease burden of LCMV is likely underestimated, as many mild or atypical infections are misclassified as nonspecific viral illnesses. This diagnostic gap creates an urgent need for improved surveillance tools and molecular research targeting key viral proteins, such as the glycoprotein complex (GP) and nucleoprotein (NP), which are essential for viral entry, replication, and immune recognition.
From a molecular and immunological perspective, LCMV has become a cornerstone model in virology and immunology research, particularly for understanding adaptive immune responses to viral infection. The virus has been extensively used to study T-cell–mediated immunity, viral persistence, and immune exhaustion. During infection, viral antigens presented by infected cells trigger strong CD8+ cytotoxic T-cell responses, which are critical for viral clearance. However, in cases of chronic infection, prolonged antigen exposure can lead to functional exhaustion of both CD4+ and CD8+ T cells, often characterized by upregulation of inhibitory immune checkpoints such as PD-1. These mechanisms have provided valuable insights into immune regulation and have influenced modern immunotherapy research for chronic viral infections and cancer. In addition, mapping of LCMV-derived T-cell epitopes has significantly advanced our understanding of antigen presentation and immune memory formation. Because of these characteristics, LCMV remains one of the most widely used experimental systems for investigating antiviral immunity, vaccine design, and host-virus interactions.
Clinically, LCMV infection presents a spectrum of disease manifestations ranging from mild febrile illness to severe neurological complications. In immunocompetent adults, infection often progresses to aseptic meningitis, encephalitis, or meningoencephalitis, making it an important but frequently overlooked cause of central nervous system infections. Epidemiological studies have shown that a measurable proportion of suspected meningitis cases may test positive for LCMV antibodies or viral RNA, underscoring its relevance in clinical diagnostics. Even more concerning is the virus's role as a fetal teratogen. Maternal infection during pregnancy can lead to congenital LCMV infection, which is associated with devastating developmental abnormalities including hydrocephalus, periventricular calcifications, chorioretinitis, and severe neurodevelopmental impairment. Mortality among congenitally infected infants is estimated to approach one-third, while a large proportion of survivors experience lifelong neurological sequelae. Despite these serious outcomes, no specific antiviral therapy for LCMV infection has yet been approved, leaving supportive care as the primary clinical management strategy. Consequently, expanding research into LCMV viral targets, host immune responses, and antiviral drug development remains a critical priority for improving diagnostic accuracy, therapeutic options, and public health awareness.
Alternate Names for LCMV
Lymphocytic choriomeningitis virus; LCMV; virus;
Loading ......
